Takeda Pharmaceutical Company Limited, a global pharma company headquartered in Japan, has announced that its Board of Directors has approved an executive compensation recoupment policy (“clawback policy”). The policy is aimed at strengthening the company’s commitment to corporate governance. The policy will take effect on April 1, 2020 and apply to short-term incentive compensation beginning…